171 related articles for article (PubMed ID: 3488185)
21. Cause-effect relationships between zymogen activation and other early events in secretagogue-induced acute pancreatitis.
Van Acker GJ; Weiss E; Steer ML; Perides G
Am J Physiol Gastrointest Liver Physiol; 2007 Jun; 292(6):G1738-46. PubMed ID: 17332471
[TBL] [Abstract][Full Text] [Related]
22. Peritoneal lavage with aprotinin in patients with severe acute pancreatitis. Effects on plasma and peritoneal levels of trypsin and leukocyte proteases and their major inhibitors.
Berling R; Borgström A; Ohlsson K
Int J Pancreatol; 1998 Aug; 24(1):9-17. PubMed ID: 9746884
[TBL] [Abstract][Full Text] [Related]
23. Immunoreactive trypsins in sera from dogs before and after induction of experimental pancreatitis.
Borgström A; Ohlsson K
Hoppe Seylers Z Physiol Chem; 1980 May; 361(5):625-31. PubMed ID: 6159294
[TBL] [Abstract][Full Text] [Related]
24. Mechanism of kinin release during experimental acute pancreatitis in rats: evidence for pro- as well as anti-inflammatory roles of oedema formation.
Griesbacher T; Rainer I; Tiran B; Fink E; Lembeck F; Peskar BA
Br J Pharmacol; 2003 May; 139(2):299-308. PubMed ID: 12770935
[TBL] [Abstract][Full Text] [Related]
25. Missorting of cathepsin B into the secretory compartment of CI-MPR/IGFII-deficient mice does not induce spontaneous trypsinogen activation but leads to enhanced trypsin activity during experimental pancreatitis--without affecting disease severity.
Meister T; Niehues R; Hahn D; Domschke W; Sendler M; Lerch MM; Schnekenburger J
J Physiol Pharmacol; 2010 Oct; 61(5):565-75. PubMed ID: 21081800
[TBL] [Abstract][Full Text] [Related]
26. Polyamine catabolism in relation to trypsin activation and apoptosis in experimental acute pancreatitis.
Jin HT; Lämsä T; Nordback PH; Hyvönen MT; Räty S; Nordback I; Herzig KH; Alhonen L; Sand J
Pancreatology; 2011; 11(2):83-91. PubMed ID: 21525776
[TBL] [Abstract][Full Text] [Related]
27. Plasma alpha 2-macroglobulin-trypsin complexlike substance (MTLS) in pancreatic disease.
Kato M; Hayakawa S; Naruse S; Kitagawa M; Nakae Y; Hayakawa T
J Clin Lab Anal; 1996; 10(6):399-402. PubMed ID: 8951609
[TBL] [Abstract][Full Text] [Related]
28. Patterns of immunoreactive trypsin in serum from patients with acute abdominal disorders.
Borgström A; Lasson A; Ohlsson K
Scand J Clin Lab Invest; 1989 Dec; 49(8):757-62. PubMed ID: 2617132
[TBL] [Abstract][Full Text] [Related]
29. Interaction between trypsinogen isoforms in genetically determined pancreatitis: mutation E79K in cationic trypsin (PRSS1) causes increased transactivation of anionic trypsinogen (PRSS2).
Teich N; Le Maréchal C; Kukor Z; Caca K; Witzigmann H; Chen JM; Tóth M; Mössner J; Keim V; Férec C; Sahin-Tóth M
Hum Mutat; 2004 Jan; 23(1):22-31. PubMed ID: 14695529
[TBL] [Abstract][Full Text] [Related]
30. Determination of human pancreatic cationic trypsinogen in serum by radioimmunoassay.
Geokas MC; Largman C; Brodrick JW; Johnson JH
Am J Physiol; 1979 Jan; 236(1):E77-83. PubMed ID: 434151
[TBL] [Abstract][Full Text] [Related]
31. Change of pancreatic enzymes, pancreatic stone protein (PSP), and plasma alpha(2)-macroglobulin-trypsin complex-like substance (MTLS) in the activation of pancreatic juice.
Kato M; Hayakawa S; Naruse S; Kitagawa M; Ishiguro H; Nakae Y; Hayakawa T
Pancreas; 1997 Nov; 15(4):345-9. PubMed ID: 9361087
[TBL] [Abstract][Full Text] [Related]
32. Does antecedent ethanol intake affect course of taurocholate pancreatitis in rats?
Dlugosz JW; Wroblewski E; Poplawski C; Gabryelewicz A; Andrzejewska A
Dig Dis Sci; 1997 May; 42(5):944-52. PubMed ID: 9149046
[TBL] [Abstract][Full Text] [Related]
33. Trypsin-alpha 1-protease inhibitor complexes in serum and clinical course of acute pancreatitis.
Borgström A; Lasson A
Scand J Gastroenterol; 1984 Nov; 19(8):1119-22. PubMed ID: 6085419
[TBL] [Abstract][Full Text] [Related]
34. Induction of IkappaB-kinase by cholecystokinin is mediated by trypsinogen activation in rat pancreatic lobules.
Tando Y; Algül H; Schneider G; Weber CK; Weidenbach H; Adler G; Schmid RM
Digestion; 2002; 66(4):237-45. PubMed ID: 12592100
[TBL] [Abstract][Full Text] [Related]
35. Pancreatic secretory proteins in sera from rats before and after induction of experimental pancreatitis.
Marks WH; Genell S; Hjelmqvist B; Ohlsson K
Scand J Gastroenterol; 1984 Jun; 19(4):552-60. PubMed ID: 6611580
[TBL] [Abstract][Full Text] [Related]
36. Trypsinogen-activation peptides in experimental rat pancreatitis: prognostic implications and histopathologic correlates.
Schmidt J; Fernández-del Castillo C; Rattner DW; Lewandrowski K; Compton CC; Warshaw AL
Gastroenterology; 1992 Sep; 103(3):1009-16. PubMed ID: 1499902
[TBL] [Abstract][Full Text] [Related]
37. Digestive enzymes and protease inhibitors in plasma from patients with acute pancreatitis.
Dubick MA; Mar G; Mayer AD; Majumdar AP; McMahon MJ; Geokas MC
Pancreas; 1987; 2(2):187-94. PubMed ID: 2442742
[TBL] [Abstract][Full Text] [Related]
38. Studies on the activation of canine trypsinogens in vitro.
Borgström A; Ohlsson K
Biochim Biophys Acta; 1979 Dec; 571(2):284-93. PubMed ID: 92342
[TBL] [Abstract][Full Text] [Related]
39. Dexamethasone affects inflammation but not trypsinogen activation in experimental acute pancreatitis.
Muller CA; Belyaev O; Appelros S; Buchler M; Uhl W; Borgstrom A
Eur Surg Res; 2008; 40(4):317-24. PubMed ID: 18303267
[TBL] [Abstract][Full Text] [Related]
40. Trypsin and activation of circulating trypsinogen contribute to pancreatitis-associated lung injury.
Hartwig W; Werner J; Jimenez RE; Z'graggen K; Weimann J; Lewandrowski KB; Warshaw AL; Fernández-del Castillo C
Am J Physiol; 1999 Nov; 277(5):G1008-16. PubMed ID: 10564107
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
